3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
20
Neoplasms
17
Lung Neoplasms
11
Carcinoma, Non-Small-Cell Lung
9
Uterine Cervical Neoplasms
5
Prostatic Neoplasms
5
Pancreatic Neoplasms
5
Colorectal Neoplasms
5
Brain Neoplasms
5
Ovarian Neoplasms
4
Myelodysplastic Syndromes
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Carcinoma, Hepatocellular
4
Triple Negative Breast Neoplasms
3
Skin Neoplasms
3
Neoplasm Metastasis
3
Kidney Neoplasms
3
Carcinoma, Renal Cell
3
Uveal Melanoma
2
Recurrence
2
Myeloproliferative Disorders
2
Lymphoma, Non-Hodgkin
2
Lymphoma, B-Cell
2
Lymphoma
2
Lung Diseases
2
Hodgkin Disease
2
Head and Neck Neoplasms
2
Glioma
2
Glioblastoma
2
Interventions
Echocardiography
2
empagliflozin
1
Social Determinants of Health
1
Hematologic Tests
1
Environmental Biomarkers
1
Carvedilol
1
Cardiography, Impedance
1
Blood Pressure Determination
1
(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cardiotoxicity
×
Blood Specimen Collection
×
90 days
×
Clear all
No trials found.